Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

9.860
-0.210-2.09%
Volume:21.27M
Turnover:208.89M
Market Cap:113.61B
PE:24.80
High:10.040
Open:9.955
Low:9.670
Close:10.070
52wk High:10.720
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.56
T/O Rate:0.18%
Dividend:0.29
Dividend Rate:2.94%
EPS(LYR):0.398
ROE:20.90%
ROA:10.70%
PB:2.58
PE(LYR):24.80
PS:3.10

Loading ...

Hong Kong Stocks Open Flat as Pharma Shares Lead Gains; Innovent Rises Nearly 2%

Stock News
·
Sep 21

Movement Alert|CSPC PHARMA Rises 3.02% in Regular Trading, Boosted by Strong H1 Earnings and Pipeline Milestones

Market Focus
·
Sep 21

CSPC Pharmaceutical Group Stock Rises 0.9% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 18

Movement Alert|CSPC PHARMA Rises 3.45% in Regular Trading, H1 Adjusted Net Profit Surges 165.8% on Strong Innovative Drug Revenue

Market Focus
·
Sep 18

CSPC Pharmaceutical Invites New Shareholders to Opt for Electronic Corporate Communications; Default Choice Effective 17 Oct 2026

Bulletin Express
·
Sep 17

CSPC Pharma H1 2026: Profit Surges 139%, License Fees Drive 57% Finished-Drug Growth

Bulletin Express
·
Sep 17

CSPC Pharmaceutical Publishes 2026 Interim Report Online; Shareholders May Request Printed Copies

Bulletin Express
·
Sep 17

CSPC Pharma Begins Diabetes Drug Trial in China

MT Newswires Live
·
Sep 16

CSPC Pharma Initiates Phase II Clinical Trial of SYH2069 Injection for Type 2 Diabetes at First Chinese Study Center

Stock News
·
Sep 16

CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug

MT Newswires Live
·
Sep 15

Cspc Pharmaceutical Says Sys6010 Granted Breakthrough Therapy Designation by NMPA

Reuters
·
Sep 15

CSPC Pharma's Novel Drug SYS 6010 Receives Breakthrough Therapy Designation in China for Advanced Non-Small Cell Lung Cancer

Stock News
·
Sep 15

CSPC Pharmaceutical - Sys6010 Granted Breakthrough Therapy Designation by Nmpa in China for Nsclc

THOMSON REUTERS
·
Sep 15

CSPC Pharmaceutical Group Stock Sheds 1.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 15

Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice

Stock News
·
Sep 15

CSPC Pharmaceutical Group Stock Rallies 1.8% in Hong Kong

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Stock News
·
Sep 11

CSPC Pharmaceutical Group Stock Slips 3.6% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 10

Global Equities Roundup: Market Talk

Dow Jones
·
Sep 10